Adaptimmune Therapeutics shares owned by Lumbard Investment Counseling
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Lumbard Investment Counseling
from 13F filings
Historical chart of Lumbard Investment Counseling investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Lumbard Investment Counseling consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Adaptimmune Therapeutics by Lumbard Investment Counseling
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $15k | 114k | 0.13 |
More positions owned by Lumbard Investment Counseling
View all positions for Lumbard Investment Counseling